 |
|
Pyridostigmine Treatment Trial in Neurogenic Orthostatic Hypotension
Wolfgang Singer, MD;
Paola Sandroni, MD, PhD;
Tonette L. Opfer-Gehrking;
Guillermo A. Suarez, MD;
Caroline M. Klein, MD;
Stacy Hines;
Peter C. O’Brien, PhD;
Jeffrey Slezak;
Phillip A. Low, MD
Arch Neurol. 2006;63:513-518. Published online February 13, 2006 (doi:10.1001/archneur.63.4.noc50340).
Background Midodrine hydrochloride is the only drug demonstrated in a placebo-controlled treatment trial to improve orthostatic hypotension (OH) but it significantly worsens supine hypertension. By enhancing ganglionic transmission, pyridostigmine bromide can potentially ameliorate OH without worsening supine hypertension.
Objective To evaluate the efficacy of a single 60-mg dose of pyridostigmine bromide, alone or in combination with a subthreshold (2.5 mg) or suprathreshold (5 mg) dose of midodrine hydrochloride, compared with placebo.
Design We report a double-blind, randomized, 4-way cross-over study of pyridostigmine in the treatment of neurogenic OH. A total of 58 patients with neurogenic OH were enrolled. After 1 day of baseline measurements, patients were given 4 treatments (3 active treatments [60 mg of pyridostigmine bromide; 60 mg of pyridostigmine bromide and 2.5 mg of midodrine hydrochloride; 60 mg of pyridostigmine bromide and 5 mg of midodrine hydrochloride] and a placebo) in random order on successive days. Blood pressure (BP) and heart rate were measured, both supine and standing, immediately before treatment and hourly for 6 hours after the treatment was given.
Results No significant differences were seen in the supine BP, either systolic (P = .36) or diastolic (P = .85). In contrast, the primary end point of the fall in standing diastolic BP was significantly reduced (P = .02) with treatment. Pairwise comparison showed significant reduction by pyridostigmine alone (BP fall of 27.6 mm Hg vs 34.0 mm Hg with placebo; P = .04) and pyridostigmine and 5 mg of midodrine hydrochloride (BP fall of 27.2 mm Hg vs 34.0 mm Hg with placebo; P = .002). Standing BP improvement significantly regressed with improvement in OH symptoms.
Conclusions Pyridostigmine significantly improves standing BP in patients with OH without worsening supine hypertension. The greatest effect is on diastolic BP, suggesting that the improvement is due to increased total peripheral resistance.
Author Affiliations: Department of Neurology, Mayo Medical Center, Rochester, Minn.
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Comparative Efficacy of Yohimbine Against Pyridostigmine for the Treatment of Orthostatic Hypotension in Autonomic Failure
Shibao et al.
Hypertension 2010;56:847-851.
ABSTRACT
| FULL TEXT
What Rare Autonomic Disorders Can Teach Us About Human Cardiovascular Pharmacology
Jordan
Hypertension 2010;56:811-813.
FULL TEXT
Multiple system atrophy: current and future approaches to management
Flabeau et al.
Therapeutic Advances in Neurological Disorders 2010;3:249-263.
ABSTRACT
Preventing and treating orthostatic hypotension: As easy as A, B, C
FIGUEROA et al.
Cleveland Clinic Journal of Medicine 2010;77:298-306.
ABSTRACT
| FULL TEXT
How to manage falls in community dwelling older adults: a review of the evidence
McKay and Anderson
Postgrad. Med. J. 2010;86:299-306.
ABSTRACT
| FULL TEXT
Cardiac Autonomic Neuropathy in Diabetes: A clinical perspective
Pop-Busui
Diabetes Care 2010;33:434-441.
FULL TEXT
The Newcastle protocols 2008: an update on head-up tilt table testing and the management of vasovagal syncope and related disorders
Parry et al.
Heart 2009;95:416-420.
FULL TEXT
Invited Article: Autonomic ganglia: Target and novel therapeutic tool
Vernino et al.
Neurology 2008;70:1926-1932.
ABSTRACT
| FULL TEXT
Neurogenic orthostatic hypotension: chasing "the fall"
Gupta and Nair
Postgrad. Med. J. 2008;84:6-14.
ABSTRACT
| FULL TEXT
Pyridostigmine in the Treatment of Orthostatic Intolerance
Gales and Gales
The Annals of Pharmacotherapy 2007;41:314-318.
ABSTRACT
| FULL TEXT
Pharmacokinetics of Pyridostigmine in a Child With Postural Tachycardia Syndrome
Filler et al.
Pediatrics 2006;118:e1563-e1568.
ABSTRACT
| FULL TEXT
Evidently...
Lehman
Evid. Based Med. 2006;11:102-102.
FULL TEXT
Other articles noted
Evid. Based Med. 2006;11:127-128.
FULL TEXT
|
